Twilight fund fades away: Meanwhile, six BioCrossroads-backed VCs are just getting started

Its specialty is developing local life sciences startups. But its partners can't raise any more money. So the sun is setting on Twilight Venture Partners. Meanwhile, the six venture capital firms BioCrossroads staked with its $73 million Indiana Future Fund have just three local investments to show among them. Venture investments take time, the six IFF recipients argue. And their first duty is to earn the high rate of return the IFF's organizers demand. That means significant proof of concept...

 

You have accessed IBJ.com Premium online content

IBJ.com Premium online content is identified by locked premium or unlocked premium symbol to the right of the headline. Access to all IBj.com Premium online content requires a paid IBJ.com Premium subscription and the subscriber to be logged in using their email and password. See subscription options below.

Log In if you are a subscriber to IBJ.com Premium Online

...Or choose the IBJ subscription that's right for you:

7 Day Subscription

$4.95 per week

IBJ.com
Premium online

Order Now
   

1 Year Subscription

$1.25 per week

IBJ.com
Premium online

Order Now
 

1 Year Subscription

$1.52 per week

IBJ Print
only

Order Now

 

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT